BG
BPMC
Bellevue Group’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.5M | Buy |
+284,900
| New | +$36.5M | 0.8% | 32 |
|
|
2025
Q1 | – | Sell |
-3,200
| Closed | -$279K | – | 152 |
|
|
2024
Q4 | $279K | Hold |
3,200
| – | – | 0.01% | 139 |
|
|
2024
Q3 | $296K | Sell |
3,200
-1,900
| -37% | -$176K | ﹤0.01% | 139 |
|
|
2024
Q2 | $550K | Hold |
5,100
| – | – | 0.01% | 126 |
|
|
2024
Q1 | $484K | Buy |
+5,100
| New | +$484K | 0.01% | 131 |
|
|
2022
Q2 | – | Sell |
-26,000
| Closed | -$1.66M | – | 175 |
|
|
2022
Q1 | $1.66M | Buy |
26,000
+500
| +2% | +$31.9K | 0.02% | 138 |
|
|
2021
Q4 | $2.73M | Buy |
+25,500
| New | +$2.73M | 0.03% | 140 |
|
|
2020
Q1 | – | Sell |
-20,200
| Closed | -$1.62M | – | 219 |
|
|
2019
Q4 | $1.62M | Buy |
20,200
+4,400
| +28% | +$352K | 0.03% | 137 |
|
|
2019
Q3 | $1.16M | Buy |
15,800
+300
| +2% | +$22K | 0.02% | 140 |
|
|
2019
Q2 | $1.46M | Buy |
+15,500
| New | +$1.46M | 0.03% | 136 |
|